Immunome Inc. IMNM said the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application for varegacestat, ...
Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities
A panel of antibodies against an undisclosed solid tumor target from Nectin Therapeutics A panel of antibodies against an undisclosed solid tumor target from Bluefin Biomedicine Four antibodies ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...
Immunome, Inc. (the "Company") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BOTHELL, Wash. & MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)-- Immunome, Inc. (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, ...
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today recognized the ...
Shares of micro-cap biopharma Immunome Inc (NASDAQ:IMNM) are indicated to open Thursday's session sharply higher. What Happened: Immunome, which focuses on developing antibody therapies, said its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results